WEX Inc (NYSE:WEX) is set to release its Q4 2024 earnings on Feb 6, 2025. The consensus estimate for Q4 2024 revenue is ...
Novo Nordisk (NVO) reported better-than-expected operating profits for Q4 2024 on Wednesday, thanks mainly to its GLP-1 drugs, including its popular weight loss therapy Wegovy, which added DKK 19.9B ...
Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.
Novo Nordisk (NVO) said on Wednesday that its emissions rose by nearly a quarter in 2024 and will continue to increase up to 2030 as production increases to meet demand for its obesity blockbuster ...